Glucocorticoids’ treatment impairs the medium-term immunogenic response to sars-cov-2 mrna vaccines in systemic lupus erythematosus patients

HIGHLIGHTS

  • who: Silvia Garcia-Cirera from the Taulu00ed Hospital University of have published the research: Glucocorticoidsu2019 treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients, in the Journal: Scientific Reports Scientific Reports
  • what: This study aims to evaluate the medium-term response to SARS-CoV-2 vaccination in SLE patients under different therapy regimes compared to healthy individuals. To interpret the results provided, it is important to consider that the study evaluates the preservation of the immunological response in the medium-term, that is, within a period . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?